GUFIC BIO PERFECT ROUNDING BOTTOM PATTERN ON CHARTS, PERFECT PICK FOR MEDIUM TERM INVESTMENTS. CMP -78
The price failed to break our support zone so many times, it seems like that is an area where buyers are stepping in and push the price higher any other ideas?? please comment your idea
Placing was at 6.15p Jupiter fund seller out - TR1 to confirm BoD own 11% of the company Acquisition of hVIVO back in December 2019 New presentation online at £28.6m mcap we are undervalued I have 8p as 1st target but we could breakout eventually & head to 9.15p then pullback to 8p & continue the bull trend after. Will re-evaluate once we hit 8p. Company looks...
Renko price movement above ATR and a strong move.
21-May-20 16:10 ET AMRN Amarin announces trial to evaluate effects of VASCEPA on patients with COVID-19 (7.28 -0.18) Amarin today announced support for a clinical trial to investigate the effects of icosapent ethyl (IPE) (VASCEPA) on inflammatory biomarkers and other patient outcomes in individuals with COVID-19. The trial primary endpoint is the effect of...
WOW, looks pretty cool. Do I want it though, not right now, no... Its starting to build up is how I look at it. From 3.75 to 4.15 is amazing buying power for you to actually make some AMAZING gains.... Invest Smart Can't predict the future but it looks promising...
Two reasons for posting this chart. 1) MNK is a long standing established generic and specialty manufacturer with products that have real usage. This is NOT a one hit wonder biotech. It would be bought out before full bankruptcy. 2) More importantly, when was the last time you've seen a CLEAR bullish divergence on a MONTHLY chart? This will be a bag I hold...
First off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. That being said, let me get into my insights. There was rumors that AstraZeneca wanted to merge w/ Gilead. However, it looks like this may not happen. Until, the books are closed don't get your hopes up, but invest as if you expect...
🧑⚕️ Pfizer recently announced that a clinical trial of its drug Ibrance hasn't worked out as a long-term treatment for breast cancer. This news is unfortunate on a few levels, but specifically, in terms of price, the impact isn't great. Upon releasing the news PFE dumped as analyst began to revise earnings expectations downward. This sell-off caused a reversal of...
All, See my previous post on my baby aka favorite stock. My entry was $2.28 on this. There pipeline was epic, FDA approvals and no price movement. Now it just hit every scanner and radar out there. I would not buy in now of course, but over time it will come back and retest the last high it left from. It may happen quickly but I would put my alert around 50% of...
All, I think this is a buy and hold over weekend scenario. FDA approval is no joke (well at least in trading ;) lol). I think this is a gap up Monday and overall could double actually based on chart positioning. TA Wise: we are forming an ascending triangle and topping out. However this is a bullish pattern. Very clear on 4H vs 15M we have yet to break full...
All, I think we are coming to a double bottom soon. The weekly on QLGN it's obvious there was a massive double top + merger made it sail down. The Question here is where does it end? It is essentially down over 45%. It is going to hit that trend line coming down and most likely fail if you want to swing that. Overall it will recover just a matter of how long. **...
This is an oldie but goodie gonna hit 70 $ before U know it...
CVS is not just a pharmacy anymore, it is a healthcare brand Minute clinics with healthcare providers, pharmacies, but most importantly, one of the top insurers in the country. This means from top to bottom, CVS will handle your outpatient visit, insurance claim, and dispense your medication. One stop shop. Their future is bright Technicals: Huge inverse head and...
Will the bulls continue pushing the price of Bridgebio Pharma through the resistance? RSI 14 shows no indication of their stocks being overbought and the pharma industry is doing well, so I think yes. But let´s wait for the next high of the MACD to see whether it converges or diverges with the price. In the case of a conversion, I call a breakthrough and long...
The Pharma Index still looks weak, this week candle is bearish candle closed at its lows. Micro structure is also of lower lows lower highs. Next support for the index is at 8800 and 8400 level. Chances are index is in a mood to consolidate for some time.
Just liked to share my thoughts and views......
There's a head and shoulders formation on the intraday chart for SUN PHARMA. Advise caution. Good short opportunity!